Risk-Tolerant Investors Should Take A Chance On ChromaDex Corporation (NASDAQ: CDXC) – Marketing Sentinel
Home  »  Company   »  Risk-Tolerant Investors Should Take A Chance On Ch...

Risk-Tolerant Investors Should Take A Chance On ChromaDex Corporation (NASDAQ: CDXC)

During the last session, ChromaDex Corporation (NASDAQ:CDXC)’s traded shares were 0.53 million, with the beta value of the company hitting 1.78. At the end of the trading day, the stock’s price was $1.69, reflecting an intraday gain of 3.05% or $0.05. The 52-week high for the CDXC share is $10.78, that puts it down -537.87 from that peak though still a striking 10.06% gain since the share price plummeted to a 52-week low of $1.52. The company’s market capitalization is $119.45M, and the average trade volume was 460.04K shares over the past three months.

ChromaDex Corporation (NASDAQ:CDXC) trade information

ChromaDex Corporation (CDXC) registered a 3.05% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.05% in intraday trading to $1.69 this Friday, 05/13/22, hitting a weekly high. The stock’s 5-day price performance is -4.52%, and it has moved by -24.22% in 30 days. Based on these gigs, the overall price performance for the year is -75.51%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

ChromaDex Corporation (CDXC) estimates and forecasts

Statistics show that ChromaDex Corporation has outperformed its competitors in share price, compared to the industry in which it operates. ChromaDex Corporation (CDXC) shares have gone down -72.56% during the last six months, with a year-to-date growth rate more than the industry average at 35.00% against -0.10. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 12.50% this quarter and then jump 53.80% in the quarter after that. In the rating firms’ projections, revenue will increase 17.70% compared to the previous financial year.

Revenue for the current quarter is expected to be $19.68 million as predicted by 5 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to $20.79 million by the end of Sep 2022.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -33.50%. While earnings are projected to return -23.80% in 2022.

CDXC Dividends

ChromaDex Corporation is due to release its next quarterly earnings between August 01 and August 05. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

ChromaDex Corporation (NASDAQ:CDXC)’s Major holders

ChromaDex Corporation insiders own 39.95% of total outstanding shares while institutional holders control 32.52%, with the float percentage being 54.15%. Yong Rong (HK) Asset Management Ltd is the largest shareholder of the company, while 123 institutions own stock in it. As of Mar 30, 2022, the company held over 4.07 million shares (or 5.96% of all shares), a total value of $10.02 million in shares.

The next largest institutional holding, with 3.2 million shares, is of Blackrock Inc.’s that is approximately 4.68% of outstanding shares. At the market price on Dec 30, 2021, these shares were valued at $11.95 million.

Also, the Mutual Funds coming in first place with the largest holdings of ChromaDex Corporation (CDXC) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. Data provided on Dec 30, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 1.48 million shares. This amounts to just over 2.17 percent of the company’s overall shares, with a $5.54 million market value. The same data shows that the other fund manager holds slightly less at 1.08 million, or about 1.58% of the stock, which is worth about $3.03 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts